Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11491129 | Oral formulations of bipolar trans carotenoids | Robert Murray | 2022-11-08 |
| 11278621 | Trans carotenoids, their synthesis, formulation and uses | Marc Lanz | 2022-03-22 |
| 11185523 | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer | — | 2021-11-30 |
| 11147859 | Diffusion enhancing compounds and their use alone or with thrombolytics | — | 2021-10-19 |
| 10130689 | Diffusion enhancing compounds and their use alone or with thrombolytics | — | 2018-11-20 |
| 10016384 | Oral formulations of bipolar trans carotenoids | Robert Murray | 2018-07-10 |
| 9950067 | Trans carotenoids, their synthesis, formulation and uses | Marc Lanz | 2018-04-24 |
| 9604899 | Bipolar trans carotenoid salts and their uses | Raymond C. Grabiak | 2017-03-28 |
| 8974822 | Oral formulations of bipolar trans carotenoids | Robert Murray | 2015-03-10 |
| 8901174 | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease | — | 2014-12-02 |
| 8293804 | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease | — | 2012-10-23 |
| 8269027 | Bipolar trans carotenoid salts and their uses | Raymond C. Grabiak | 2012-09-18 |
| 8206751 | Class of therapeutics that enhance small molecule diffusion | — | 2012-06-26 |
| 8030350 | Trans carotenoids, their synthesis, formulation and uses | Marc Lanz | 2011-10-04 |
| 8017653 | Bipolar trans carotenoid salts and their uses | Raymond C. Grabiak | 2011-09-13 |
| 7919527 | Bipolar trans carotenoid salts and their uses | Raymond C. Grabiak | 2011-04-05 |
| 7759506 | Bipolar trans carotenoid salts and their uses | Raymond C. Grabiak | 2010-07-20 |
| 7351844 | Bipolar trans carotenoid salts and their uses | Raymond C. Grabiak | 2008-04-01 |
| 6060511 | Trans-sodium crocetinate, methods of making and methods of use thereof | — | 2000-05-09 |
| 5420024 | Process for synthesis of acylated HMG-CoA reductase inhibitors from a lactone diol precursor using Candida cylindracea | Giorgio Carta, Michael J. Conder, Robert W. Stieber, Victor A. Vinci, Timothy W. Weber | 1995-05-30 |